A detailed history of Strs Ohio transactions in Organon & Co. stock. As of the latest transaction made, Strs Ohio holds 82,621 shares of OGN stock, worth $1.22 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
82,621
Previous 60,017 37.66%
Holding current value
$1.22 Million
Previous $1.24 Million 27.21%
% of portfolio
0.01%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$18.65 - $23.03 $421,564 - $520,570
22,604 Added 37.66%
82,621 $1.58 Million
Q2 2024

Aug 05, 2024

BUY
$17.45 - $21.96 $1.05 Million - $1.32 Million
59,916 Added 59322.77%
60,017 $1.24 Million
Q4 2023

Jan 30, 2024

SELL
$10.95 - $17.32 $870,765 - $1.38 Million
-79,522 Reduced 99.87%
101 $1,000
Q3 2023

Oct 26, 2023

BUY
$16.59 - $23.77 $1.32 Million - $1.89 Million
79,522 Added 78734.65%
79,623 $1.38 Million
Q2 2023

Jul 31, 2023

SELL
$19.27 - $24.63 $1.14 Million - $1.46 Million
-59,299 Reduced 99.83%
101 $2,000
Q1 2023

Aug 02, 2023

BUY
$21.42 - $32.08 $1.27 Million - $1.9 Million
59,299 Added 58711.88%
59,400 $1.4 Million
Q1 2023

Apr 27, 2023

BUY
$21.42 - $32.08 $255,304 - $382,361
11,919 Added 25.1%
59,400 $1.4 Million
Q4 2022

Jan 26, 2023

BUY
$23.31 - $28.61 $154,545 - $189,684
6,630 Added 16.23%
47,481 $1.33 Million
Q3 2022

Oct 27, 2022

SELL
$23.4 - $34.25 $134,105 - $196,286
-5,731 Reduced 12.3%
40,851 $955,000
Q2 2022

Jul 25, 2022

BUY
$31.66 - $38.9 $1.47 Million - $1.81 Million
46,481 Added 46020.79%
46,582 $1.57 Million
Q4 2021

Jan 24, 2022

SELL
$28.67 - $37.13 $80,103 - $103,741
-2,794 Reduced 96.51%
101 $3,000
Q3 2021

Oct 22, 2021

SELL
$28.63 - $35.64 $2,863 - $3,564
-100 Reduced 3.34%
2,895 $94,000
Q2 2021

Jul 26, 2021

BUY
$28.45 - $38.0 $85,207 - $113,810
2,995 New
2,995 $90,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.